Company Active LTD

Company profile

Smith & Nephew UK Limited

Smith+Nephew Medical Devices and Advanced Wound Care | Global

Smith+Nephew is a global portfolio medical technology business. We design and make technology that takes the limits off living.

CRN
04421171
Founded
2002
Age
24

Overview

Legal name
SMITH & NEPHEW UK LIMITED
Region
East of England
Registered address
BUILDING 5, CROXLEY PARK
HATTERS LANE
WATFORD
HERTFORDSHIRE
ENGLAND
WD18 8YE
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller Controls 24
1
Company Active LTD
Smith & Nephew UK Limited
CRN 04421171
2
Direct and ultimate controller Active PLC
Smith & Nephew PLC
CRN 00324357

Company events

Reference milestones and recent Companies House filing stream events.

5 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

31 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

17 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

19 Apr
2002

Incorporated

Inception

Company registered at Companies House

Public funding

8 awards
First funded
2010
Funded years
2010, 2011, 2013, 2014, 2016, 2017
Age at first award
8 years

Projects

2017 Collaborative R&D

Production Capable Additive Manufacturing of Polymers (ProAMP)

1 Oct 2017 to 31 Mar 2020

Awarded
£6,250
Total cost £12,500

3D Printing and Additive Manufacturing (AM) has been heralded as a revolutionary technology which will impact on almost every aspect of manufacturing. It promises to be a technology which will change the manufacturing paradigm This is undoubtedly true, but before AM can be regarded as an established mass production technology it must metamorphose from a l...

2017 Collaborative R&D Lead participant

Resorbable Osteoplasty for Orthopedic Applications

1 Aug 2017 to 31 Oct 2019

Awarded
£61,326
Total cost £122,651

The primary objective of this 2 year collaborative research project is to develop the world’s first resorbable osteoplasty for minimally invasive intramedullary stabilisation of osteoporotic bone fractures, which is a growing international healthcare problem that contributes to the £2.3bn annual cost of fractures to the NHS. In the UK, the population over...

2016 Feasibility Studies Lead participant

Enhanced Performance of Internal Limb Lenthening Prosthesis by Pasma Immersion Ion Implantation

1 Sep 2016 to 31 Aug 2017

Awarded
£25,383
Total cost £50,767

The objective of this 1 year feasibility study is to improve the performance of limb lengthening intramedullary prosthesis (LLN) for deformity correction & acquired trauma through plasma immersion ion implantation (PIII) of the internal components. It is hypothesized that PIII treatment will improve lubricity between these mating surfaces reducing the tor...

2016 Collaborative R&D

Smart Responsive Antimicrobial Implants

1 Mar 2016 to 29 Feb 2020

Awarded
£136,814
Total cost £273,627

The primary objective of this collaborative research project is to develop a smart antimicrobial orthopaedic implant suitable for mass production in the established and emerging markets. The 3yr project is industry led by a global medical device company (Smith and Nephew) collaborating with a charitable NHS hospital trust and academia. The antimicrobial t...

2014 Knowledge Transfer Partnership

The University of Nottingham and Smith & Nephew UK Limited

1 Dec 2014 to 30 Sep 2016

Awarded
Unknown

To transform the current business model in the wound care market.

2013 Collaborative R&D Lead participant

SmartFix - A fully automated 6-degree-of-freedom measuring fixator for optimised control of bone healing

1 Dec 2013 to 31 Aug 2015

Awarded
£55,656
Total cost £111,312

This applied research study provides an opportunity to develop the world’s first intelligent orthopedic External Fixator (Ex Fix) suitable for mass production using enabling technology, which addresses a pressing healthcare need in terms of improved patient outcomes through promoting the growth of stronger bone tissue, & reduced healthcare costs by decrea...

2011 Collaborative R&D Lead participant

High value manufacturing of PEEK composite orthopedic implants

1 Aug 2011 to 31 Jul 2014

Awarded
£237,221
Total cost £474,442

The primary objective of this collaborative research project is to develop low cost, PEEK composite intramedullary (IM) nails for pre-clinical evaluation in an ovine tibial fracture model to determine whether an implant modulus of elasticity closer to bone would encourage faster healing through reduced stress shielding and increased micromotion. Although ...

2010 Fast Track

EktoTherix: translation from R&D of a regenerative tissue scaffold for repair of surgical excision wounds

1 Aug 2010 to 31 Mar 2011

Awarded
£17,500
Total cost £35,000

Awaiting Public Summary

Product types

Collaborative R&D Fast Track Feasibility Studies Knowledge Transfer Partnership